Payment overview · 2025
General Payments
$53.23
3 reported records · 3 companies
Healthcare provider profile · identity verified
Thomas A Bostaph, CRNP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health · CUMBERLAND, MD · NPI 1093769127
Verified facts
What the public records show
CMS Open Payments records show Thomas A Bostaph, CRNP received $53.23 in general payments during 2025 across 3 reported records.
Abbott Laboratories accounted for 39.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 32 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $21.06 | 39.6% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $17.31 | 32.5% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $14.86 | 27.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $53.23 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $21.06 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $17.31 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $17.31 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $14.86 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 32 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
32 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 721 | 174 |
| Lisinopril | Lisinopril | 530 | 138 |
| Amlodipine Besylate | Amlodipine Besylate | 480 | 126 |
| Atorvastatin Calcium | Atorvastatin Calcium | 383 | 102 |
| Simvastatin | Simvastatin | 264 | 69 |
| Omeprazole | Omeprazole | 263 | 67 |
| Metoprolol Succinate | Metoprolol Succinate | 224 | 66 |
| Meloxicam | Meloxicam | 217 | 61 |
| Tramadol Hcl | Tramadol Hcl | 215 | 51 |
| Pantoprazole Sodium | Pantoprazole Sodium | 209 | 61 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 207 | 53 |
| Alprazolam | Alprazolam | 201 | 33 |
| Escitalopram Oxalate | Escitalopram Oxalate | 176 | 43 |
| Furosemide | Furosemide | 175 | 62 |
| Tamsulosin Hcl | Tamsulosin Hcl | 173 | 48 |
| Hydrochlorothiazide | Hydrochlorothiazide | 168 | 50 |
| Metoprolol Tartrate | Metoprolol Tartrate | 165 | 48 |
| Gabapentin | Gabapentin | 162 | 46 |
| Losartan Potassium | Losartan Potassium | 153 | 41 |
| Metformin Hcl | Metformin Hcl | 139 | 38 |
| Lorazepam | Lorazepam | 130 | 27 |
| Trazodone Hcl | Trazodone Hcl | 127 | 26 |
| Eliquis | Apixaban | 119 | 25 |
| Zolpidem Tartrate | Zolpidem Tartrate | 118 | 19 |
| Allopurinol | Allopurinol | 111 | 33 |
| Diclofenac Sodium | Diclofenac Sodium | 111 | 24 |
| Famotidine | Famotidine | 110 | 26 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 95 | 21 |
| Tizanidine Hcl | Tizanidine Hcl | 91 | 28 |
| Spironolactone | Spironolactone | 88 | 25 |
| Sertraline Hcl | Sertraline Hcl | 86 | 21 |
| Lovastatin | Lovastatin | 85 | 19 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 83 | 26 |
| Potassium Chloride | Potassium Chloride | 79 | 22 |
| Farxiga | Dapagliflozin Propanediol | 78 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 76 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 71 | 15 |
| Synthroid | Levothyroxine Sodium | 69 | 17 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 68 | 54 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 67 | 11 |
| Atenolol | Atenolol | 66 | 15 |
| Jardiance | Empagliflozin | 66 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 65 | 18 |
| Carvedilol | Carvedilol | 62 | 18 |
| Donepezil Hcl | Donepezil Hcl | 59 | 16 |
| Celecoxib | Celecoxib | 57 | 13 |
| Ezetimibe | Ezetimibe | 57 | suppressed |
| Glipizide Er | Glipizide | 57 | 13 |
| Clonazepam | Clonazepam | 56 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 56 | 15 |
| Metformin Hcl Er | Metformin Hcl | 56 | 11 |
| Amoxicillin | Amoxicillin | 54 | 40 |
| Azithromycin | Azithromycin | 53 | 45 |
| Januvia | Sitagliptin Phosphate | 52 | suppressed |
| Xarelto | Rivaroxaban | 52 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 51 | 42 |
| Montelukast Sodium | Montelukast Sodium | 51 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 50 | 17 |
| Ramipril | Ramipril | 50 | 13 |
| Ibuprofen | Ibuprofen | 49 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 48 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 44 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 43 | 14 |
| Verapamil Er | Verapamil Hcl | 42 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 41 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 40 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 40 | 13 |
| Sucralfate | Sucralfate | 40 | suppressed |
| Finasteride | Finasteride | 39 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 39 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 38 | suppressed |
| Glipizide | Glipizide | 38 | suppressed |
| Ondansetron Odt | Ondansetron | 38 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 38 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 36 | suppressed |
| Fenofibrate | Fenofibrate | 35 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 34 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 34 | 12 |
| Clonidine Hcl | Clonidine Hcl | 33 | suppressed |
| Naproxen | Naproxen | 33 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 33 | suppressed |
| Methylprednisolone | Methylprednisolone | 32 | 26 |
| Ozempic | Semaglutide | 32 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 31 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 30 | suppressed |
| Pregabalin | Pregabalin | 30 | 12 |
| Valsartan | Valsartan | 30 | suppressed |
| Mirtazapine | Mirtazapine | 29 | suppressed |
| Nifedipine Er | Nifedipine | 29 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 29 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 29 | 15 |
| Aripiprazole | Aripiprazole | 28 | suppressed |
| Diazepam | Diazepam | 28 | suppressed |
| Tradjenta | Linagliptin | 28 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 27 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 26 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 18 |
| Cephalexin | Cephalexin | 25 | 20 |
| Hydrocortisone | Hydrocortisone | 25 | suppressed |
| Glimepiride | Glimepiride | 23 | suppressed |
| Memantine Hcl | Memantine Hcl | 23 | suppressed |
| Fluconazole | Fluconazole | 22 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 22 | suppressed |
| Bupropion Xl | Bupropion Hcl | 21 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 21 | suppressed |
| Lansoprazole | Lansoprazole | 21 | suppressed |
| Baclofen | Baclofen | 20 | suppressed |
| Levetiracetam | Levetiracetam | 20 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 20 | suppressed |
| Mupirocin | Mupirocin | 20 | suppressed |
| Prednisone | Prednisone | 20 | 12 |
| Acarbose | Acarbose | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 19 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 19 | suppressed |
| Olanzapine | Olanzapine | 19 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 19 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 19 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 18 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Gemfibrozil | Gemfibrozil | 17 | suppressed |
| Loperamide | Loperamide Hcl | 17 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Testosterone | Testosterone | 16 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 16 | suppressed |
| Carisoprodol | Carisoprodol | 15 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 15 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 15 | suppressed |
| Klor-Con M20 | Potassium Chloride | 15 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 15 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 15 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 15 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 15 | suppressed |
| Trulicity | Dulaglutide | 15 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Latanoprost | Latanoprost | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 14 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 13 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 13 | suppressed |
| Invokana | Canagliflozin | 13 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Methotrexate | Methotrexate Sodium | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Victoza 3-Pak | Liraglutide | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 12 | suppressed |
| Mesalamine Er | Mesalamine | 12 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 12 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 12 | suppressed |
| Repaglinide | Repaglinide | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Entresto | Sacubitril/Valsartan | 11 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 11 | suppressed |
| Mesalamine Dr | Mesalamine | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Nystatin | Nystatin | 11 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 11 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 11 | suppressed |
| Tadalafil | Tadalafil | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $53.23 · 3 records | Abbott Laboratories | FREESTYLE LIBRE 3, Ozempic, Rybelsus, The Cologuard Plus Collection Kit | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error